Trials / Completed
CompletedNCT03460873
Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 432 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | holmium laser enucleation of the prostate | undergo holmium laser enucleation of the prostate |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2019-11-07
- Completion
- 2019-11-28
- First posted
- 2018-03-09
- Last updated
- 2019-12-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03460873. Inclusion in this directory is not an endorsement.